Hyaluronan activation of the Nlrp3 inflammasome contributes to the development of airway hyperresponsiveness

Environmental Health Perspectives

Volumn 120, Issue 12, 2012, Pages 1692-1698

  Feng, Feifei ^a,b   Li, Zhuowei ^a   Potts Kant, Erin N ^a   Wu, Yiming ^b   Michael Foster, W ^a   Williams, Kristi L ^a,c   Hollingsworth, John W ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Asthma; Environment; Extracellular matrix; Innate immunity; Ozone; Toll like receptor

Indexed keywords

CRYOPYRIN; CYTOKINE; HYALURONIC ACID; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; METHACHOLINE; OZONE; PROTEIN;

AGAR GEL ELECTROPHORESIS; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; IMMUNOBLOTTING; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT ALLERGY; UPREGULATION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER PROTEINS; CASPASE 1; HYALURONIC ACID; IMMUNOBLOTTING; INFLAMMASOMES; INTERLEUKIN-1BETA; MALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; OZONE; REAL-TIME POLYMERASE CHAIN REACTION;

MUS;

EID: 84870544293     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205188     Document Type: Article

References (43)

1. Al-Hegelan M, Tighe RM, Castillo C, Hollingsworth JW. 2011. Ambient ozone and pulmonary innate immunity. Immunol Res 49(1-3):173-191.
2. Backus GS, Howden R, Fostel J, Bauer AK, Cho HY, Marzec J, et al. 2010. Protective role of interleukin-10 in ozone-induced pulmonary inflammation. Environ Health Perspect 118:1721-1727.
3. Barker BR, Taxman DJ, Ting JP. 2011. Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol 23(5):591-597.
4. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, Hornung V. 2011. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 187(2):613-617.
5. Bell M, McDermott A, Zeger S, Samet J, Dominici F. 2004. Ozone and short-term mortality in 95 US urban communities, 1987-2000. JAMA 292(19):2372-2378.
6. Bell ML, Peng RD, Dominici F. 2006. The exposure-response curve for ozone and risk of mortality and the adequacy of current ozone regulations. Environ Health Perspect 114:532-536.
7. Berman JD, Fann N, Hollingsworth JW, Pinkerton K, Rom WN, Szema AM, et al. 2012. Health benefits from large scale ozone reduction in the United States. Environ Health Perspect 120:1404-1410.
8. Caceres AI, Brackmann M, Elia MD, Bessac BF, del Camino D, D'Amours M, et al. 2009. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci USA 106(22):9099-9104.
9. Chang HH, Zhou J, Fuentes M. 2010. Impact of climate change on ambient ozone level and mortality in southeastern United States. Int J Environ Res Public Health 7(7):2866-2880.
10. Dentener MA, Vernooy JH, Hendriks S, Wouters EF. 2005. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 60(2):114-119.
11. Foster WM, Brown RH, Macri K, Mitchell CS. 2000. Bronchial reactivity of healthy subjects: 18-20 h postexposure to ozone. J Appl Physiol 89(5):1804-1810.
12. Garantziotis S, Li Z, Potts EN, Kimata K, Zhuo L, Morgan DL, et al. 2009. Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem 284(17):11309-11317.
13. Garantziotis S, Li Z, Potts EN, Lindsey JY, Stober VP, Polosukhin VV, et al. 2010. TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med 181(7):666-675.
14. Guarda G, Zenger M, Yazdi AS, Schroder K, Ferrero I, Menu P, et al. 2011. Differential expression of NLRP3 among hematopoietic cells. J Immunol 186(4):2529-2534.
15. Hatch GE, Slade R, Harris LP, McDonnell WF, Devlin RB, Koren HS, et al. 1994. Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med 150(3):676-683.
16. Hoffman HM, Brydges SD. 2011. Genetic and molecular basis of inflammasome-mediated disease. J Biol Chem 286(13):10889-10896.
17. Hollingsworth JW, Cook DN, Brass DM, Walker JK, Morgan DL, Foster WM, et al. 2004. The role of toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170(2):126-132.
18. Ito K, De Leon SF, Lippmann M. 2005. Associations between ozone and daily mortality: analysis and meta-analysis. Epidemiology 16(4):446-457.
19. Jin C, Flavell RA. 2010. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 30(5):628-631.
20. Johnston RA, Mizgerd JP, Flynt L, Quinton LJ, Williams ES, Shore SA. 2007. Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice. Am J Respir Cell Mol Biol 37(4):477-484.
21. Kehrl HR, Vincent LM, Kowalsky RJ, Horstman DH, O'Neil JJ, McCartney WH, et al. 1987. Ozone exposure increases respiratory epithelial permeability in humans. Am Rev Respir Dis 135(5):1124-1128.
22. Kim CS, Alexis NE, Rappold AG, Kehrl H, Hazucha MJ, Lay JC, et al. 2011. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med 183(9):1215-1221.
23. Kleeberger SR, Reddy SP, Zhang LY, Cho HY, Jedlicka AE. 2001. Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 280(2):L326-333.
24. Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, et al. 1989. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 139(2):407-415.
25. Li Z, Potts EN, Piantadosi CA, Foster WM, Hollingsworth JW. 2010. Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide. J Immunol 185(11):6891-6898.
26. Li Z, Potts-Kant EN, Garantziotis S, Foster WM, Hollingsworth JW. 2011. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. PLoS One 6(11):e27137; doi:10.1371/journal.pone.0027137 [Online 4 November 2011].
27. Liang J, Jiang D, Jung Y, Xie T, Ingram J, Church T, et al. 2011. Role of hyaluronan and hyaluronan-binding proteins in human asthma. J Allergy Clin Immunol 128(2):403-411.
28. Moore PE, Lahiri T, Laporte JD, Church T, Panettieri RA Jr, Shore SA. 2001. Selected contribution: synergism between TNF-α and IL-1β in airway smooth muscle cells: implications for β-adrenergic responsiveness. J Appl Physiol 91(3):1467-1474.
29. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC:National Academies Press.
30. Park JW, Taube C, Swasey C, Kodama T, Joetham A, Balhorn A, et al. 2004. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol 30:830-836.
31. Peden DB. 2011. The role of oxidative stress and innate immunity in O3 and endotoxin-induced human allergic airway disease. Immunol Rev 242(1):91-105.
32. Que LG, Stiles JV, Sundy JS, Foster WM. 2011. Pulmonary function, bronchial reactivity, and epithelial permeability are response phenotypes to ozone and develop differentially in healthy humans. J Appl Physiol 111(3):679-687.
33. Sahu S, Lynn WS. 1978. Hyaluronic acid in the pulmonary secretions of patients with asthma. Biochem J 173(2):565-568.
34. Samet JM. 2011. The Clean Air Act and health-a clearer view from 2011. N Engl J Med 365(3):198-201.
35. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, et al. 2006. Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24(3):317-327.
36. Taylor KR, Yamasaki K, Radek KA, Nardo AD, Goodarzi H, Golenbock D, et al. 2007. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J Biol Chem 282(25):18265-18275.
37. Ting JP, Willingham SB, Bergstralh DT. 2008. NLRs at the intersection of cell death and immunity. Nat Rev Immunol 8(5):372-379.
38. Verhein KC, Jacoby DB, Fryer AD. 2008. IL-1 receptors mediate persistent, but not acute, airway hyperreactivity to ozone in guinea pigs. Am J Respir Cell Mol Biol 39(6):730-738.
39. Wiester MJ, Tepper JS, King ME, Menache MG, Costa DL. 1988. Comparative study of ozone (O3) uptake in three strains of rats and in the guinea pig. Toxicol Appl Pharmacol 96(1):140-146.
40. Williams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P, Issa R, et al. 2007. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol 103(4):1189-1195.
41. Williams AS, Nath P, Leung SY, Khorasani N, McKenzie AN, Adcock IM, et al. 2008. Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13. Eur Respir J 32(3):571-578.
42. Wu ZX, Barker JS, Batchelor TP, Dey RD. 2008. Interleukin (IL)-1 regulates ozone-enhanced tracheal smooth muscle responsiveness by increasing substance P (SP) production in intrinsic airway neurons of ferret. Respir Physiol Neurobiol 164(3):300-311.
43. Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, et al. 2009. NLRP3/cryopyrin is necessary for interleukin-1β (IL-1β) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 284(19):12762-12771.